Provenienza dei contatti di primo grado di Holli Kolkey
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Public Company | Biotechnology | 22 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Holli Kolkey tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| REGENERON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 1984 and is headquartered in Marlborough, MA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| MYRIAD GENETICS, INC. | Medical Specialties | Chief Operating Officer | |
| CHEMOCENTRYX, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Human Resources Officer | |
| ATRECA, INC. | Biotechnology | Director/Board Member | |
| NURIX THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Parke-Davis & Co. Ltd.
 Parke-Davis & Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Parke-Davis & Co. Ltd. is a British pharmaceutical company. The company is based in St. Helier, UK. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Roche Group
 Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | Real Estate Development | Corporate Officer/Principal | |
| University of California, Los Angeles | College/University | Undergraduate Degree Corporate Officer/Principal | |
| University of California, Berkeley | College/University | Doctorate Degree Undergraduate Degree | |
| The University of Colorado | College/University | Undergraduate Degree | |
| University of Maryland | College/University | Doctorate Degree | |
| University of Michigan | College/University | Undergraduate Degree Doctorate Degree | |
| MEDIVATION INC | Pharmaceuticals: Major | Founder Director/Board Member Director of Finance/CFO | |
| Universidad Complutense de Madrid | College/University | Undergraduate Degree | |
Ysios Capital Partners SGEIC SA
 Ysios Capital Partners SGEIC SA Investment ManagersFinance Ysios Capital Partners SGEIC SA (Ysios Capital) is a venture capital firm founded in 2007 by Joël Jean Pierre Jean-Mairet, Julia Salaverría Monfort and Josep Lluís Sanfeliu Benet. The firm is headquartered in San Sabastian, Spain with additional office in Barcelona. | Investment Managers | Private Equity Investor Private Equity Investor | |
| SAGIMET BIOSCIENCES INC. | Pharmaceuticals: Major | Director/Board Member | |
| ARGENX SE | Pharmaceuticals: Other | Director/Board Member | |
Jewish Hospital
 Jewish Hospital Hospital/Nursing ManagementHealth Services Part of Community Health Systems, Inc., Jewish Hospital is a hospital. The company is based in Cincinnati, OH. Jewish Hospital was acquired by Mercy Health Partners, Inc. (Pennsylvania), a NPO of Community Health Systems, Inc. from Jewish Foundation of Cincinnati on March 01, 2010 for $180 million. | Hospital/Nursing Management | Corporate Officer/Principal | |
| Goizueta Business School-Emory | College/University | Undergraduate Degree | |
| KITE PHARMA INC | Biotechnology | Founder | |
| University of California | College/University | Corporate Officer/Principal | |
Inbiomotion SL
 Inbiomotion SL Medical SpecialtiesHealth Technology Inbiomotion SL designs and develops diagnostic assays. It focus on genetic biomarkers, which predict the bone-specific metastases in cancer patients. The firm develops biomarker in breast cancer primary tumors for predicting the bone relapse. The company was founded by in 2010 and is headquartered in Barcelona, Spain. | Medical Specialties | Director/Board Member | |
| UCLA Anderson School of Management | College/University | Masters Business Admin | |
Rainier Therapeutics, Inc.
 Rainier Therapeutics, Inc. BiotechnologyHealth Technology Rainier Therapeutics, Inc. operates as a biotechnology company that develops a targeted biologic for the potential treatment of metastatic bladder cancer. It provides Vofatamab, an antibody that is focused on the fibroblast growth factor of bladder and other cancer. The company was founded by Stephen Lau and is headquartered in San Leandro, CA. | Biotechnology | Director/Board Member | |
Transcelerate Biopharma, Inc.
 Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Transcelerate Biopharma, Inc. is a non-profit consortium that collaborates with pharmaceutical and biotechnology companies to improve the delivery of new medicines. The non-profit company is based in King of Prussia, PA. The organization's mission is to identify, prioritize, design, and facilitate implementation of solutions to drive the efficient, effective, and high-quality delivery of new medicines. Transcelerate has 20 member companies and 30+ initiatives focused on improving the patient and site experience, enhancing sponsor efficiencies and drug safety, and harmonizing processes and sharing information. The company was founded by Garry Arthur Neil, and Janice Chang has been the CEO of the company since 2014. | Biotechnology | Director/Board Member | |
| The University of Colorado School of Medicine | College/University | Doctorate Degree | |
| CYTOMX THERAPEUTICS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
Axovant Sciences, Inc.
 Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sio Gene Therapies, Inc., Axovant Sciences, Inc. is a company that manufactures and distributes pharmaceutical products. The company is based in New York, NY. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| UNITY BIOTECHNOLOGY, INC. | Biotechnology | Director/Board Member Director of Finance/CFO Comptroller/Controller/Auditor | |
PACT Pharma, Inc.
 PACT Pharma, Inc. Pharmaceuticals: MajorHealth Technology PACT Pharma, Inc. develops pharmaceutical products. It offers personalizes adoptive cell therapies with neoantigen-targeted T cells against cancer. The company is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Founder Founder Founder | |
| RAPT THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer President Chief Tech/Sci/R&D Officer | |
Kalthera, Inc.
 Kalthera, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Immpact Bio USA, Inc., Kalthera, Inc. provides progressive clinical trials services. The company is based in Westlake Village, CA. The company was founded by Yvonne Chen, Cristina Puig Saus, Jim Johnston, Antoni Ribas. Jim Johnston has been the CEO since incorporation. Kalthera was acquired by Immpact Bio USA, Inc. on July 22, 2021. | Miscellaneous Commercial Services | Founder | |
| TANGO THERAPEUTICS, INC. | Biotechnology | Founder | |
The Parker Institute For Cancer Immunotherapy
 The Parker Institute For Cancer Immunotherapy Miscellaneous Commercial ServicesCommercial Services The Parker Institute for Cancer Immunotherapy is a research organization that aims to accelerate the development of breakthrough immune therapies to turn all cancers into curable diseases. The Parker Institute for Cancer Immunotherapy is based in San Francisco, CA. The private company conducts clinical trials to tackle the toughest cancers and answer the hardest questions in immunotherapy. The institute coordinates cancer research efforts between the best scientists, clinicians, and partners in the industry. The company has legal experts who help their researchers navigate the intellectual property process and turn their cancer immunotherapy discoveries into treatments. It was founded by Sean N. Parker, Adam Kolom, Michael Polansky. | Miscellaneous Commercial Services | Director/Board Member | |
Breakpoint Therapeutics GmbH
 Breakpoint Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Breakpoint Therapeutics GmbH engages in the discovery and development of anti-cancer drugs. It aims to advance to clinical development first-in-class oncology drugs that interfere with DNA repair and replication stress tolerance pathways. The company is headquartered in Hamburg, Germany. | Pharmaceuticals: Major | Director/Board Member | |
| New York University School of Medicine | College/University | Corporate Officer/Principal |
Statistiche
Distribuzione geografica
| Stati Uniti | 40 |
| Spagna | 4 |
| Regno Unito | 2 |
| Svizzera | 2 |
| Paesi Bassi | 2 |
Settori
| Health Technology | 30 |
| Consumer Services | 12 |
| Commercial Services | 4 |
| Finance | 3 |
| Health Services | 2 |
Posizioni
| Director/Board Member | 109 |
| Corporate Officer/Principal | 45 |
| Independent Dir/Board Member | 44 |
| Director of Finance/CFO | 25 |
| Chief Tech/Sci/R&D Officer | 20 |
Contatti più connessi
| Insiders | |
|---|---|
| Clarence Machado | 31 |
| Kathryn Falberg | 30 |
| Terry Rosen | 19 |
| Jennifer Jarrett | 18 |
| Juan Jaen | 16 |
| Antoni Ribas | 15 |
| Andrew Perlman | 14 |
| Yasunori Kaneko | 13 |
| David Lacey | 12 |
| Merdad Parsey | 11 |
| Johanna Mercier | 9 |
| Linda Higgins | 8 |
| Alexander Azoy | 8 |
| Steve Young | 8 |
| Dimitry Nuyten | 7 |
- Borsa valori
- Insiders
- Holli Kolkey
- Connessioni Società
